Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
95,963,102
-
Total 13F shares
-
16,922,876
-
Share change
-
+1,253,525
-
Total reported value
-
$747,921,361
-
Put/Call ratio
-
71%
-
Price per share
-
$44.89
-
Number of holders
-
81
-
Value change
-
+$55,850,290
-
Number of buys
-
44
-
Number of sells
-
35
Institutional Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q2 2014
As of 30 Jun 2014 Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) had 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 16,922,876 shares of stock of the company.
Largest 10 holders included TPG Group Holdings (SBS) Advisors, Inc., Capital Research Global Investors, COLUMBIA WANGER ASSET MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP LLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, WELLINGTON MANAGEMENT CO LLP, Visium Asset Management, LP, Capital World Investors, and ALLIANCEBERNSTEIN L.P..
This table shows 81 institutional shareholders of the security as of 30 Jun 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.